Mayra Elisa Lorenzo Iglesias, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Human T-lymphotropic virus 1 | 1 | 2016 | 143 | 0.500 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2016 | 166 | 0.490 |
Why?
|
| Skin | 3 | 2016 | 4489 | 0.440 |
Why?
|
| Drug Eruptions | 1 | 2016 | 335 | 0.430 |
Why?
|
| Scleromyxedema | 1 | 2022 | 8 | 0.210 |
Why?
|
| Ligases | 1 | 2002 | 330 | 0.180 |
Why?
|
| Herpesvirus 8, Human | 1 | 2002 | 254 | 0.170 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 542 | 0.160 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 663 | 0.150 |
Why?
|
| Viral Proteins | 2 | 2002 | 1797 | 0.150 |
Why?
|
| Endocytosis | 1 | 2002 | 951 | 0.140 |
Why?
|
| Ubiquitin | 1 | 2002 | 839 | 0.140 |
Why?
|
| Exanthema | 3 | 2016 | 502 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 1365 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2001 | 718 | 0.120 |
Why?
|
| Leg Injuries | 1 | 2016 | 179 | 0.120 |
Why?
|
| Mastocytosis | 1 | 2016 | 151 | 0.110 |
Why?
|
| Sarcoma, Kaposi | 1 | 2016 | 375 | 0.100 |
Why?
|
| Mastocytosis, Cutaneous | 1 | 2012 | 14 | 0.100 |
Why?
|
| Pruritus | 1 | 2016 | 378 | 0.100 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2012 | 19 | 0.100 |
Why?
|
| Blister | 1 | 2012 | 90 | 0.100 |
Why?
|
| Organ Transplantation | 1 | 2022 | 1174 | 0.100 |
Why?
|
| Sarcoma | 1 | 2022 | 1802 | 0.090 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1646 | 0.090 |
Why?
|
| Rhabdomyolysis | 1 | 2012 | 151 | 0.090 |
Why?
|
| Biopsy | 2 | 2016 | 6763 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 2495 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12976 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 5849 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 528 | 0.050 |
Why?
|
| Immunity, Active | 1 | 2001 | 58 | 0.050 |
Why?
|
| Viral Structural Proteins | 1 | 2001 | 93 | 0.040 |
Why?
|
| Lip | 1 | 2022 | 195 | 0.040 |
Why?
|
| Genes, MHC Class I | 1 | 2001 | 236 | 0.040 |
Why?
|
| Vaccination | 1 | 2012 | 3426 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2001 | 654 | 0.040 |
Why?
|
| Mucins | 1 | 2022 | 567 | 0.040 |
Why?
|
| Edema | 1 | 2022 | 760 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2022 | 866 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 1314 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2001 | 1555 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6113 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2001 | 2927 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 1892 | 0.030 |
Why?
|
| Cromolyn Sodium | 1 | 2012 | 76 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2001 | 4137 | 0.020 |
Why?
|
| Humans | 8 | 2022 | 765968 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 59889 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2012 | 572 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2012 | 874 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 1880 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 171117 | 0.010 |
Why?
|
| Male | 3 | 2016 | 363698 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1946 | 0.010 |
Why?
|
| Female | 1 | 2016 | 396112 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2012 | 6972 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 36386 | 0.010 |
Why?
|
| Animals | 1 | 2001 | 168764 | 0.000 |
Why?
|
| Middle Aged | 1 | 2012 | 223009 | 0.000 |
Why?
|